InvestorsHub Logo

ilovetech

11/17/18 2:20 PM

#160489 RE: Jt0082 #160484

Moreover, without a positive outcome study, Lovaza was BO for $30 PPS if I remember correctly.

ILT

staccani

11/17/18 2:20 PM

#160490 RE: Jt0082 #160484

What he meant is that Afib increase was irrelevant since, whilst it normally increases stroke risk, Vascepa actually REDUCED the risk of stroke by 28%

Biobillionair

11/17/18 3:00 PM

#160503 RE: Jt0082 #160484

You miss my point. Despite AFIB Vascepa reduces risks.—BB